Merck & Co., Inc.
Merck & Co., Inc. 6MK.DE Peers
See (6MK.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6MK.DE | €69.20 | -0.43% | 173.8B | 11.53 | €6.00 | +3.84% |
| LLY.DE | €677.00 | +0.39% | 641.6B | 63.15 | €10.72 | +0.68% |
| JNJ.DE | €136.16 | +0.24% | 327.6B | 17.35 | €7.85 | +3.03% |
| 4AB.DE | €167.00 | -0.12% | 295B | 81.46 | €2.05 | +3.17% |
| ZEG.DE | €128.10 | +0.12% | 198.6B | 29.45 | €4.35 | +2.14% |
| AMG.DE | €254.75 | -0.16% | 137B | 26.62 | €9.57 | +3.33% |
| GIS.DE | €98.72 | +0.84% | 122.8B | 23.73 | €4.16 | +2.68% |
| PFE.F | €21.00 | +1.99% | 119.4B | 17.65 | €1.19 | +6.72% |
| PFE.DE | €21.00 | +1.82% | 119.4B | 17.35 | €1.21 | +6.73% |
| SNW.DE | €87.64 | -0.89% | 106.8B | 17.56 | €4.99 | +4.48% |
Stock Comparison
6MK.DE vs LLY.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, LLY.DE has a market cap of 641.6B. Regarding current trading prices, 6MK.DE is priced at €69.20, while LLY.DE trades at €677.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas LLY.DE's P/E ratio is 63.15. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs JNJ.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, JNJ.DE has a market cap of 327.6B. Regarding current trading prices, 6MK.DE is priced at €69.20, while JNJ.DE trades at €136.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas JNJ.DE's P/E ratio is 17.35. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, 6MK.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs 4AB.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, 4AB.DE has a market cap of 295B. Regarding current trading prices, 6MK.DE is priced at €69.20, while 4AB.DE trades at €167.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas 4AB.DE's P/E ratio is 81.46. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, 6MK.DE is more volatile compared to 4AB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs ZEG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, ZEG.DE has a market cap of 198.6B. Regarding current trading prices, 6MK.DE is priced at €69.20, while ZEG.DE trades at €128.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas ZEG.DE's P/E ratio is 29.45. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, 6MK.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs AMG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, AMG.DE has a market cap of 137B. Regarding current trading prices, 6MK.DE is priced at €69.20, while AMG.DE trades at €254.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas AMG.DE's P/E ratio is 26.62. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, 6MK.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GIS.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, GIS.DE has a market cap of 122.8B. Regarding current trading prices, 6MK.DE is priced at €69.20, while GIS.DE trades at €98.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas GIS.DE's P/E ratio is 23.73. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, 6MK.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.F Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, PFE.F has a market cap of 119.4B. Regarding current trading prices, 6MK.DE is priced at €69.20, while PFE.F trades at €21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas PFE.F's P/E ratio is 17.65. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, PFE.DE has a market cap of 119.4B. Regarding current trading prices, 6MK.DE is priced at €69.20, while PFE.DE trades at €21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas PFE.DE's P/E ratio is 17.35. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs SNW.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, SNW.DE has a market cap of 106.8B. Regarding current trading prices, 6MK.DE is priced at €69.20, while SNW.DE trades at €87.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas SNW.DE's P/E ratio is 17.56. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, 6MK.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BRM.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, BRM.DE has a market cap of 87.2B. Regarding current trading prices, 6MK.DE is priced at €69.20, while BRM.DE trades at €42.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas BRM.DE's P/E ratio is 18.31. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, 6MK.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.SG Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, BAYN.SG has a market cap of 26.1B. Regarding current trading prices, 6MK.DE is priced at €69.20, while BAYN.SG trades at €26.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, 6MK.DE is more volatile compared to BAYN.SG. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, 6MK.DE is priced at €69.20, while BAYN.DE trades at €26.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas BAYN.DE's P/E ratio is -7.98. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, 6MK.DE is more volatile compared to BAYN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs IDP.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, IDP.DE has a market cap of 17.2B. Regarding current trading prices, 6MK.DE is priced at €69.20, while IDP.DE trades at €117.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas IDP.DE's P/E ratio is 13.28. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GS7.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 173.8B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, 6MK.DE is priced at €69.20, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.53, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.